Literature DB >> 2897088

Interrelationships between ornithine, glutamate, and GABA. II. Consequences of inhibition of GABA-T and ornithine aminotransferase in brain.

G Daune1, N Seiler.   

Abstract

The objective of the present study was to compare the effects of elevation of GABA concentration and those of inactivation of L-ornithine: 2-oxoacid aminotransferase (OAT) on the in vivo metabolism of L-ornithine (Orn) in brain. Vigabatrin (4-aminohex-5-enoic acid) and gabaculine (5-amino-1,3-cyclohexadienyl carboxylic acid), two well known inactivators of GABA-T, were used to elevate brain GABA concentrations. The latter inactivates OAT also. Transamination of Orn is, from a quantitative point of view, a significant reaction in mouse brain. GABA is a feed-back regulator of OAT. Within GABAergic neurons Orn concentration may be regulated by endogenous GABA. Extensive inactivation of OAT causes a considerable increase of Orn concentration, both in synaptosomes and in non-synaptosomal compartments. The results are compatible with a role of Orn as precursor of glutamate and/or GABA in certain neurons.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897088     DOI: 10.1007/bf00971857

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

1.  PURIFICATION AND PROPERTIES OF RAT LIVER ORNITHINE DELTA-TRANSAMINASE.

Authors:  H J STRECKER
Journal:  J Biol Chem       Date:  1965-03       Impact factor: 5.157

2.  Interrelationships between ornithine, glutamate and GABA-I. Feed-back inhibition of ornithine aminotransferase by elevated brain GABA levels.

Authors:  N Seiler; H Spraggs; G Daune
Journal:  Neurochem Int       Date:  1987       Impact factor: 3.921

3.  The in vivo inhibition of GABA-transaminase by gabaculine.

Authors:  R R Rando; F W Bangerter
Journal:  Biochem Biophys Res Commun       Date:  1977-06-20       Impact factor: 3.575

4.  Developmental changes of putreanine in vertebrate brains.

Authors:  N Seiler; S Sarhan; B Knodgen
Journal:  Int J Dev Neurosci       Date:  1985       Impact factor: 2.457

5.  Regulatory interrelations between GABA and polyamines. I. Brain GABA levels and polyamine metabolism.

Authors:  N Seiler; G Bink; J Grove
Journal:  Neurochem Res       Date:  1979-08       Impact factor: 3.996

6.  A new synaptosomal biosynthetic pathway of glutamate and GABA from ornithine and its negative feedback inhibition by GABA.

Authors:  Y Yoneda; E Roberts; G W Dietz
Journal:  J Neurochem       Date:  1982-06       Impact factor: 5.372

7.  gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice.

Authors:  M J Jung; B Lippert; B W Metcalf; P Böhlen; P J Schechter
Journal:  J Neurochem       Date:  1977-11       Impact factor: 5.372

8.  Developmental changes in mouse brain polyamine metabolism.

Authors:  S I Laitinen; P H Laitinen; O A Hietala; A E Pajunen; R S Piha
Journal:  Neurochem Res       Date:  1982-12       Impact factor: 3.996

9.  Metabolic inhibitors and subcellular distribution of GABA.

Authors:  S Sarhan; N Seiler
Journal:  J Neurosci Res       Date:  1979       Impact factor: 4.164

10.  Association of putrescine, spermidine, spermine, and GABA with structural elements of brain cells.

Authors:  N Seiler; K Deckardt
Journal:  Neurochem Res       Date:  1976-10       Impact factor: 3.996

View more
  9 in total

Review 1.  Thirty years beyond discovery--clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism.

Authors:  Kara R Vogel; Phillip L Pearl; William H Theodore; Robert C McCarter; Cornelis Jakobs; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2012-06-28       Impact factor: 4.982

Review 2.  Review: Normal and abnormal central nervous system GABA metabolism in childhood.

Authors:  J Jaeken; P Casaer; K D Haegele; P J Schechter
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 3.  Oxidation of polyamines and brain injury.

Authors:  N Seiler
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

4.  Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.

Authors:  Erin M MacKenzie; Suzanne L Grant; Glen B Baker; Paul L Wood
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

5.  (4S)-4-amino-5,6-heptadienoic acid (MDL 72483): a potent anticonvulsant GABA-T inhibitor.

Authors:  S Sarhan; P Casara; B Knödgen; N Seiler
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

Review 6.  Endogenous ornithine in search for CNS functions and therapeutic applications.

Authors:  N Seiler; G Daune-Anglard
Journal:  Metab Brain Dis       Date:  1993-09       Impact factor: 3.584

7.  5-Fluoromethylornithine, an irreversible and specific inhibitor of L-ornithine:2-oxo-acid aminotransferase.

Authors:  G Daune; F Gerhart; N Seiler
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

Review 8.  Ornithine Aminotransferase, an Important Glutamate-Metabolizing Enzyme at the Crossroads of Multiple Metabolic Pathways.

Authors:  Antonin Ginguay; Luc Cynober; Emmanuel Curis; Ioannis Nicolis
Journal:  Biology (Basel)       Date:  2017-03-07

9.  Preferential accumulation of the active S-(+) isomer in murine retina highlights novel mechanisms of vigabatrin-associated retinal toxicity.

Authors:  Dana C Walters; Erwin E W Jansen; Gajja S Salomons; Erland Arning; Paula Ashcraft; Teodoro Bottiglieri; Jean-Baptiste Roullet; K Michael Gibson
Journal:  Epilepsy Res       Date:  2020-12-29       Impact factor: 3.045

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.